Syncom Formulations Q3 Result 2024: Date and Time, Share Price and Target

News: Syncom Formulations India, a prominent player in the biotechnology and drugs sector, is set to announce its Q3 results for 2024. Investors and stakeholders eagerly await this update to gauge the company’s financial health and performance. In this article, we’ll delve into the key details surrounding Syncom Formulations’ Q3 results, including the date and time of the announcement, share price movements, and the target outlook.

Syncom Formulations India: A Brief Overview

Before we dive into the specifics, let’s understand a bit about Syncom Formulations India. The company operates in the pharmaceutical industry, focusing on drug formulations, research, and development. Its commitment to quality and innovation has positioned it as a trusted name in the market.

Q3 Results: What to Expect

As the Q3 results approach, here’s what investors should keep an eye on:

1. Date and Time of Announcement: The company is scheduled to release its Q3 results on February 14, 2024. Mark your calendars and stay tuned for the official communication.
2. Share Price Movement: Syncom Formulations’ share price has been subject to fluctuations. Investors will closely monitor any significant movements following the results. As of now, the share price stands at 15.24 INR.
3. Target Outlook: Analysts and experts will analyze the Q3 performance against projected targets. The company’s ability to meet or exceed expectations will impact investor sentiment.

Key Metrics

Here are some essential metrics to consider:

• Revenue: How much revenue did Syncom Formulations generate during Q3?
• Profit and Loss: Did the company report a profit or incur losses?
• Balance Sheet: What’s the financial position in terms of assets, liabilities, and equity?
• Cashflow: How efficiently is the company managing its cash?

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

About Syncom Formulations India :

Syncom Formulations (India) Limited, a prominent name in the Indian pharmaceutical industry, embodies the essence of SYNergistic COMbination for health. Established in 1995, this global pharmaceutical company has made significant strides in manufacturing and marketing a diverse range of healthcare products.

Our Journey and Strengths

Manufacturing Excellence

Syncom boasts its own state-of-the-art manufacturing facility located in Pithampur, just 30 kilometers away from Indore, the commercial capital of Madhya Pradesh, India. This robust setup enables us to produce high-quality formulations that meet global standards.

Global Reach

Operating in more than 15 countries worldwide, Syncom Formulations has registered over 400 products. Our commitment to quality and innovation has earned us recognition on the international stage.

Our Vision and Mission

Vision

“To be a fully integrated and the most admired leading global healthcare provider.”

Mission

• Customer Delight: We strive to bring a smile to every face by achieving customer delight.
• Global Impact: Our focus is on positively impacting lives through our formulation products.

Investors and stakeholders eagerly await Syncom Formulations’ Q3 results. Whether you’re a seasoned investor or a curious observer, keep an eye on the company’s official announcements and market reactions. The numbers will reveal the story behind the scenes, shaping the company’s trajectory in the competitive pharmaceutical landscape.

Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.